Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARTISTRY-3: Nemvaleukin Alfa Monotherapy and in Combination with Pembrolizumab in Advanced Solid Tumors
NCT04592653Phase 2Active, not recruiting
- Sponsor
- Mural Oncology
- Start
- Sep 2020
- Primary completion
- Jul 2024
- Modality
- Cytokines & Interferons, Fc-Fusion Proteins
- Countries
- 2
01
Overview
A Phase 2 trial of nemvaleukin alfa in solid tumor (advanced stage), sponsored by Mural Oncology. Started Sep 2020; status: active, not recruiting.
02
Drugs
nemvaleukin alfa
03
Conditions
solid tumor (advanced stage)
Beyond the preview
Go deeper on NCT04592653.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04592653.